Assyro AI

FDA Orange Book · active-ingredient family

Desipramine hydrochloride

Desipramine hydrochloride is approved as 2 brand and 16 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:NORPRAMIN · NDA 014399

2

Brand (NDA)

16

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · capsule, tablet

ProductApplicantApplicationTEApproved
NORPRAMINRLD×6VALIDUS PHARMSNDA 014399ABFeb 11, 1982
PERTOFRANE×2SANOFI AVENTIS USNDA 013621Approved Prior to Jan 1, 1982

Generic (ANDA) products (16)

ProductApplicantApplicationTEApproved
DESIPRAMINE HYDROCHLORIDE×6ALEMBICANDA 209785ABJul 07, 2021
DESIPRAMINE HYDROCHLORIDE×6INGENUS PHARMS LLCANDA 204963ABDec 26, 2017
DESIPRAMINE HYDROCHLORIDE×6ANI PHARMSANDA 205153Oct 28, 2016
DESIPRAMINE HYDROCHLORIDE×6HERITAGEANDA 207433May 05, 2016
DESIPRAMINE HYDROCHLORIDE×6AMNEAL PHARMS COANDA 208105ABMar 17, 2016
DESIPRAMINE HYDROCHLORIDE×2ACTAVIS TOTOWAANDA 074430ABFeb 09, 1996
DESIPRAMINE HYDROCHLORIDE×6CHARTWELL RXANDA 072103ABMay 24, 1988
DESIPRAMINE HYDROCHLORIDE×5ANI PHARMSANDA 071803Dec 08, 1987
DESIPRAMINE HYDROCHLORIDEACTAVIS TOTOWAANDA 071602ABOct 05, 1987
DESIPRAMINE HYDROCHLORIDEACTAVIS TOTOWAANDA 071766ABOct 05, 1987
DESIPRAMINE HYDROCHLORIDEUSL PHARMAANDA 071864Sep 09, 1987
DESIPRAMINE HYDROCHLORIDEUSL PHARMAANDA 071865Sep 09, 1987
DESIPRAMINE HYDROCHLORIDEUSL PHARMAANDA 071866Sep 09, 1987
DESIPRAMINE HYDROCHLORIDEUSL PHARMAANDA 071867Sep 09, 1987
DESIPRAMINE HYDROCHLORIDEACTAVIS TOTOWAANDA 071601ABJun 05, 1987
DESIPRAMINE HYDROCHLORIDEACTAVIS TOTOWAANDA 071588ABJun 05, 1987

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Desipramine hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.